New Long-Term Data Show Improved Survival and Lower Rates of Stroke and Pump Thrombosis for Abbott’s HeartMate 3 Heart Pump

March 11, 2018

Responsive image

ORLANDO, Fla., March 11, 2018  /PRNewswire/ — Abbott (NYSE: ABT) announced new late-breaking clinical trial data from the MOMENTUM 3 clinical study, the largest left ventricular assist device (LVAD) trial in the world to evaluate patients in need of both short-term and long-term support i…

Category: Precious Metals